PHARMACODYNAMIC AND PHARMACOKINETIC PROFILES OF SACUBITRIL/VALSARTAN (LCZ696) IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION ArticleKobalava Z., Kotovskaya Y., Averkov O., Pavlikova E., Moiseev V., Albrecht D., Chandra P., Ayalasomayajula S., Prescott M.F., Pal P., Langenickel T.H., Jordaan P., Rajman I.Cardiovascular Therapeutics. Vol. 34. 2016. P.. 191-198
APPLICATION OF RIVAROXABAN IN ACUTE CORONARY SYNDROME: EVIDENCE AND CURRENT GUIDELINES ArticleAverkov O.V.Российский кардиологический журнал. Vol. 129. 2016. P.. 68-72
THE PLACE FOR SYSTEMIC THROMBOLYSIS IN MODERN REPERFUSION METHODS FOR MYOCARDIAL INFARCTION ArticleAverkov O.V., Pavlikova E.P., Tyulkina E.E.Российский кардиологический журнал. Vol. 113. 2014. P.. 77-83
CLOPIDOGREL IN THE TREATMENT OF PATIENTS WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION: STATE-OF-ART IN 2013 ArticleAverkov O.V.Российский кардиологический журнал. Vol. 99. 2013. P.. 104-112
VENOUS THROMBOEMBOLISM IN PATIENTS WITH HEART FAILURE ArticleAverkov O.V., Shevchenko I.V., Mirilashvili T.Sh., Kobalava Zh.D.Cardiovascular Therapy and Prevention. Vol. 10. 2011. P.. 101-106
CARDIOLOGY NEWS 2009: ARTERIAL HYPERTENSION, PRIMARY AND SECONDARY PREVENTION OF ATHEROSCLEROSIS, ANTITHROMBOTIC THERAPY ArticleKobalava Zh.D., Kotovskaya Yu.V., Villevalde S.V., Averkov O.V.Kardiologiia. Vol. 50. 2010. P.. 62-72
ACETYLSALICYLIC ACID AS AN ANTI-PLATELET AGENT: WHAT FORMS SHOULD BE USED, ACCORDING TO EVIDENCE-BASED MEDICINE? ArticleAverkov O.V.Cardiovascular Therapy and Prevention. Vol. 9. 2010. P.. 61-68
FONDAPARINUX AND INVASIVE TREATMENT OF NON-ST ELEVATION ACUTE CORONARY SYNDROME ArticleAverkov O.V.Kardiologiia. Vol. 48. 2008. P.. 49-54